Table 1.
Clinical characteristics of the 936 patients with 972 gastric SETs ≤ 2 cm
| Age [year; mean ± SD; (range)] | 53.6 ± 10.2 (16–78) |
| Gender [n (%)] | |
| Male | 213 (22.8%) |
| Female | 723 (77.2%) |
| Tumor diameter [mm; mean ± SD] | 9.6 ± 3.9 |
| Location [n (%)] | |
| Fundus | 558 (57.4) |
| Corpus | 390 (40.1) |
| Angle | 3 (0.3) |
| Antrum | 21 (2.2) |
| Pathological diagnosis [n (%)] | |
| Leiomyoma | 485 (49.9) |
| GIST | 411 (42.3) |
| Schwannoma | 20 (2.1) |
| Ectopic pancreas | 12 (1.2) |
| Vascular malformation/proliferation | 8 (0.8) |
| Inflammatory tissue | 17 (1.7) |
| Hamartoma | 5 (0.5) |
| Glomus tumor | 4 (0.4) |
| Neuroendocrine neoplasm | 3 (0.3) |
| Calcified tissue | 3 (0.3) |
| Collagenoma | 2 (0.2) |
| Hemangioma | 1 (0.1) |
| Fibroma | 1 (0.1) |
| Endoscopic procedures [n (%)] | |
| BLR | 418 (43) |
| ESD | 344 (35.4) |
| EFTR | 201 (20.7) |
| STER | 9 (0.9) |
| Complete resection | 972 |
| Postoperative complications | |
| Perforation | 2 |
| Bleeding | 3 |
BLR band ligation and resection, ESD endoscopic submucosal dissection, EFTR endoscopic full-thickness resection, STER submucosal tunneling endoscopic resection